tm logo
ACIMAB
FORMALIZED

on 21 Jul 2021

Last Applicant/ Owned by

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

124 Dvora HaNevi'a6944020 Tel Aviv-Jaffa

IL

Serial Number

2121983 filed on 21st Jul 2021

Correspondent Address

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

ACIMAB

Trademark usage description

pharmaceutical preparations for the treatment of multiple sclerosis, lupus nephritis and crohn's disease.

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.


Classification kind code

11

Mark Details


Serial Number

2121983

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 06th Jul 2022
Pre-Assessment Letter Sent
Submitted for opposition 135
on 28th Feb 2022
Amendment to Application
Submitted for opposition 30
on 21st Jul 2021
Filed
Submitted for opposition 1
on 21st Jul 2021
Created
Submitted for opposition 31
on 21st Jul 2021
Formalized